Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA

Código QR

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA

We have reported that the plasma zinc concentration gradually decreases with the progression of fibrosis and is related to hepatocellular carcinoma (HCC) development. The aim of this study was to examine the impact of the zinc concentration on HCC development (study 1) and the relationship between z...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Atsushi Hosui, Takashi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/23a7b131d71d4caa81c6716491de355b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization
por: Daniel Valle-Millares, et al.
Publicado: (2022)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista D, et al.
Publicado: (2021)

Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs
por: Mercedes Márquez-Coello, et al.
Publicado: (2021)

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
por: Stefania Farcomeni, et al.
Publicado: (2021)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018)

Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
por: Matthew A Burchill, et al.
Publicado: (2021)

Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus
por: Fadwa A. Abdelwahab, et al.
Publicado: (2020)

Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals
por: Yoshimasa Tokuchi, et al.
Publicado: (2021)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Na Sun, et al.
Publicado: (2020)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Chun-Ming Hong, et al.
Publicado: (2021)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Le Wu, et al.
Publicado: (2021)

Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes
por: Liang-Hao Ding, et al.
Publicado: (2021)

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
por: Tuğrul Himmetoğlu, et al.
Publicado: (2007)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
por: D. E. Valutite, et al.
Publicado: (2018)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Laura Crocetti, et al.
Publicado: (2021)

Measuring HCC Tumor Size in MRI—The Sequence Matters!
por: Marco Armbruster, et al.
Publicado: (2021)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
por: Paola Dongiovanni, et al.
Publicado: (2021)

Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia
por: J. Estevez, et al.
Publicado: (2016)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Xiaopei Hao, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Chunye Zhang, et al.
Publicado: (2021)

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
por: Fengze Sun, et al.
Publicado: (2021)

Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Pierpaolo Biondetti, et al.
Publicado: (2021)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Alberto Zanetto, et al.
Publicado: (2021)

Direct anterior approach (DAA) vs. conventional approaches in total hip arthroplasty: A RCT meta-analysis with an overview of related meta-analyses.
por: Philip Lazaru, et al.
Publicado: (2021)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection.
por: Hung-Yin Liu, et al.
Publicado: (2021)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
por: Monica Basso, et al.
Publicado: (2021)

Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
por: Stéphane Chevaliez, et al.
Publicado: (2009)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Lorena Vigón, et al.
Publicado: (2019)

PREVALENCE OF THE HCV INFECTION AND AGE OR GENDER RELATED ASSOCIATION IN HCV-POSITIVE PATIENTS FROM GENERAL POPULATION OF LAHORE PAKISTAN
por: Muhammad Farooq, et al.
Publicado: (2019)

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib
por: Toshifumi Tada, et al.
Publicado: (2021)

Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment
por: Francesco Dituri, et al.
Publicado: (2021)

Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanisms
por: Xiang-Xu Wang, et al.
Publicado: (2021)

Social protection and poverty eradication in Ecuador
por: Mideros, Andrés Iván
Publicado: (2021)

Intervention-based stochastic disease eradication.
por: Lora Billings, et al.
Publicado: (2013)

Plan of Action for the Eradication of Poverty in Belize
Publicado: (2014)

Implementation strategy for poverty eradication in Belize
Publicado: (2014)

Comments regarding use of rifabutin for eradication
por: David Y. Graham
Publicado: (2021)

BspR/BtrA, an Anti-σ Factor, Regulates the Ability of <italic toggle="yes">Bordetella bronchiseptica</italic> To Cause Cough in Rats
por: Keiji Nakamura, et al.
Publicado: (2019)

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Yue-Ming Ling, et al.
Publicado: (2017)

High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan.
por: Chun-Yuan Lee, et al.
Publicado: (2021)